Skip to main content
. 2023 Feb 8;15(4):867. doi: 10.3390/nu15040867

Table 2.

Maternal phenotype and pregnancy outcomes throughout the study.

Outcome CON HC-CP HC-PPN
Body weight (g)
  Initial 90.7 ± 6.7 a 94.3 ± 2.1 a 94.61 ± 1.3 a
  End of pre-pregnancy 291.6 ± 8.4 a 372.5 ± 15.1 b 386.7 ± 12.4 b
  End of gestation 446.9 ± 11.3 a 488.3 ± 17.4 b 519.6 ± 14.7 b
  End of lactation 336.1 ± 11.2 a 345.9 ± 9.6 a 355.4 ± 13.5 a
Feed intake (kcal/d)
  Pre-pregnancy 63.3 ± 1.7 a 80.2 ± 3.7 b 77.3 ± 3.1 b
  Gestation 85.1 ± 3.1 a 98.2 ± 4.5 b 104.6 ± 7.3 b
  Lactation 124.3 ± 4.4 a 130.8 ± 3.3 b 132.4 ± 4.8 b
Breeding outcomes
  Reproductive success (%) * 90.00 43.75 72.73
  Time to pregnancy (days) 2.5 ± 0.5 a 2.8 ± 0.4 a 3.0 ± 0.3 a
  Litter size at birth (# pups) 14.3 ± 0.5 a 14.0 ± 0.6 a 13.6 ± 0.9 a
  Litter weight at birth (g) 88.9 ± 3.1 a 88.4 ± 5.2 a 93.7 ± 7.7 a
  Average pup weight at birth (g) 6.2 ± 0.3 a 6.3 ± 0.2 a 6.82 ± 0.1 a
Metabolic parameters
  Pre-pregnancy
    Glucose (mg/dL) 76.1 ± 6.7 72.9 ± 7.4 84.3 ± 12.4
    Insulin (µIU/mL) 65.7 ± 7.5 57.86 ± 14.5 47.5 ± 9.9
    Glucose:insulin 1.2 ± 0.1 1.8 ± 0.4 2.3 ± 0.4

* Calculated as mothers who gave birth without subsequent infanticide. CON, low-calorie control diet; HC-CP, high-calorie obese-inducing diet with casein protein; and HC-PPN, HC high-calorie diet with supplemental yellow pea protein (25%). ab Treatment groups that do not share a superscript are significantly different (p < 0.05). Data are means ± SE, and n = 7–9 per group.